2 results
Approved WMORecruiting
Primary Objective:To compare the fate of the struts in front of the side-branch using optical coherence tomography after treatment with 1. COMBO or 2. XIENCE stent using single stent strategy with side-branch fenestration in the treatment of (a)…
Approved WMORecruiting
The anti-TIM-3 monoclonal antibody MBG453 is a novel immunotherapeutic agent with promising activity seen in AML and MDS. The purpose of the current study is to assess clinical effects of MBG453 in combination with azacitidine in adult subjects with…